All News

How one day could help your patients manage their meds.

Not all drugs are incredible-and sometimes even the incredible ones have weird origins.

The FIP awards honored two international pharmacy associations for their recent campaigns.

Rivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.

EpiPen manufacturer is accused of lax investigation into problems.

Education about anticoagulants helped boost adherence rates and led to a small decrease in stroke risk.

Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.

The use of health IT has exploded in the last decade, and that means better health care.

After trials halted, FDA issues warning on off-label use of the drug.

The city's decision is the latest move against tobacco in pharmacies.

Mid Valley Pharmaceutical recalls two drugs.

A petition sent by multiple groups says yes.

In the midst of unprecedented disaster, pharmacists and pharmacies were prepared.

Why the agency says the approval of Novartis’ new therapy is historic.

New therapies hold great promise-and great danger.

The recall is just the latest in a bacterial contamination scare.

Robberies are never a good thing, but sometimes they make for the craziest stories.

An opioid scheme ends in prison and hefty fines.

Why the NABP says Canada isn't a safe alternative.

How pharmacists are helping to push vital health efforts.

Brand name drug companies are "gaming" the system, according to the FDA head.

Senate passes FDARA overwhelmingly, ahead of September deadline.

Legislators say it will help ease the problem, but the NCPA says it’s just one part of the solution.

The PBM giant is cutting down on the number of opioids new patients can buy.

The settlement is the end of a long legal battle.

New Walgreens website will showcase the chain’s research on adherence and other topics.

After many years of speculation, a number of biosimilar drugs are hitting the U.S. market.

A tricky labeling system could be affecting your patients.